Chronic Kidney Disease Stage 3 Clinical Trial
Official title:
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease - Randomized, Double-blind, Placebo-controlled Trial
The Sulforaphane Production System® in Avmacol Extra Strength (ES) supplies broccoli seed extract (glucoraphanin) and Myrosimax® (Active Myrosinase Enzyme) which helps promote sulforaphane production in your body. The investigators hypothesize that daily intake of Avmacol ES can decrease kidney disease progression rate and decrease markers of oxidative stress and inflammation in Chronic Kidney Disease (CKD) patients. They will test this hypothesis in a randomized, double-blind, placebo controlled Phase 2 clinical trial. This proposed study has been funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), R01 DK128677.
The investigators will test the safety and efficacy of Avmacol ES in Chronic Kidney Disease (CKD) patients. After having established a safe dose of 4 tablets once daily in participants with CKD Stages 3 - 4 in the pharmacokinetic (PK) phase, the investigators will enroll 100 participants from the Kidney Clinic at the University of Rochester Medical Center and Highland Hospital with CKD stages 3 - 4 who will be randomized to Avmacol ES or placebo in a 1:1 ratio in a blinded manner. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05169411 -
Preserving Kidney Function in Children With Chronic Kidney Disease
|
N/A | |
| Terminated |
NCT03529071 -
Empowering Veterans to Communicate With Healthcare Providers
|
N/A | |
| Recruiting |
NCT03311321 -
Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients
|
N/A | |
| Active, not recruiting |
NCT05198284 -
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
|
||
| Recruiting |
NCT01709994 -
Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
|
Phase 3 | |
| Active, not recruiting |
NCT05225454 -
The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
|
||
| Completed |
NCT01748396 -
Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
|
Phase 4 | |
| Completed |
NCT04012957 -
Desidustat in the Treatment of Anemia in CKD
|
Phase 3 | |
| Completed |
NCT03242252 -
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
|
Phase 3 | |
| Recruiting |
NCT01509716 -
Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
|
N/A |